IV NEWS
Events and training - December 18, 2023
3 factors to consider in vascular access device selection
Vascular access device (VAD) selection represents a crucial moment in vascular access management (VAM). “A peripheral vessel selection is not…
News and innovation December 11, 2023
Tripledemic may return to Europe this winter: Vaccination still key
Four years after COVID-19 first emerged,1 it remains difficult to forecast how severe the 2023–24 respiratory infection season will be.2,3…
“Complications of IV catheter therapy are simply the result of one complex and highly variable mechanical system—IV catheter equipment design,...
News and innovation December 4, 2023
Make the case for a vascular access team by convincing with facts
You may have heard of a vascular access team (VAT) and its benefit to patient care, but you aren't sure…
Events and training November 27, 2023
PVAM care bundles: how we can measure their economic benefit
A common procedure with high risk Peripheral intravenous catheter (PIVC) placement is the most common invasive procedure carried out at…
Events and training November 20, 2023
Danish vascular access team facilitates shift to home care
When possible, certain patients may be better treated in the comfort of their home. Before 2014, Dr Bo Gottschau noticed…
News and innovation November 6, 2023
Straight to the point: how to better manage needle phobia
Are you having trouble administering injections to patients with needle phobia? The fear of needles is frequent. An estimated 63%…
Scientific publications October 30, 2023
What can we learn from the new regional anaesthesia survey?
Over the last 20 years, regional anaesthesia practices have evolved with increased use, largely thanks to ultrasound, technical improvements and…
Fast fact
TIVA anaesthesia
Propofol-based total intravenous anaesthesia (TIVA) emits four orders of magnitude less greenhouse gases than inhaled anaesthesia with desflurane and N2O.